Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2020 Results
Castle Biosciences, Inc. - Common stock (CSTL)
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm
Check Earnings Report
Company Research
Source: Business Wire
Delivered 18,185 gene expression profile test reports in 2020Year-end 2020 cash and cash equivalents were approximately $410 millionFinal, expanded LCD for CMS coverage for DecisionDx-Melanoma test became effective on Dec. 6, 2020Launched two new skin cancer tests in 2H2020, increasing estimated in-market U.S. TAM to $2 billion FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced certain unaudited preliminary performance results for the fourth quarter and full-year 2020.“At Castle, we are committed to providing innovative, clinically actionable dermatologic tests to improve patient outcomes,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “In 2020, despite the challenges presented to us all by the global pandemic, our team remained focused on this commitment and performed exceptionally.“We del
Show less
Read more
Impact Snapshot
Event Time:
CSTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSTL alerts
High impacting Castle Biosciences, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CSTL
News
- We're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burn [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024 [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024Business Wire
- Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational CollaborationsBusiness Wire
CSTL
Earnings
- 2/28/24 - Beat
CSTL
Sec Filings
- 4/17/24 - Form EFFECT
- 4/16/24 - Form 4
- 4/12/24 - Form 144
- CSTL's page on the SEC website